{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:30:27Z","timestamp":1786631427137,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Jiangxi Province","award":["20242BAB25525"],"award-info":[{"award-number":["20242BAB25525"]}]},{"name":"Science and Technology Project of Jiangxi Provincial Health Commission","award":["2025L3050"],"award-info":[{"award-number":["2025L3050"]}]},{"name":"Jiangxi Province Graduate Students Innovation Special Fund project in 2022","award":["YC2022-B069"],"award-info":[{"award-number":["YC2022-B069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12584-2","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:43:28Z","timestamp":1786628608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis, DNA damage repair, and transporter proteins: associated with platinum sensitivity and prognosis in epithelial ovarian cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Mai","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"1","key":"12584_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025 Jan-Feb) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"12584_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.annonc.2021.02.015","volume":"32","author":"T BAERT","year":"2021","unstructured":"Baert T, Ferrero A, Sehouli J et al (2021) The systemic treatment of recurrent ovarian cancer revisited[J\/OL]. Annals of Oncology. Official J Eur Soc Med Oncol 32(6):710\u2013725. https:\/\/doi.org\/10.1016\/j.annonc.2021.02.015","journal-title":"Official J Eur Soc Med Oncol"},{"issue":"1","key":"12584_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12672-026-04702-0","volume":"17","author":"W CHEN","year":"2026","unstructured":"Chen W, Shi W, Chan H L et al (2026) Cell-intrinsic and tumor microenvironmental determinants of platinum resistance in epithelial ovarian cancer[J\/OL]. Discover Oncol 17(1):523. https:\/\/doi.org\/10.1007\/s12672-026-04702-0","journal-title":"Discover Oncol"},{"issue":"2","key":"12584_CR4","doi-asserted-by":"publisher","first-page":"101801","DOI":"10.1016\/j.gendis.2025.101801","volume":"13","author":"H LI","year":"2026","unstructured":"Li H, Sheng JJ, Zheng SA et al (2026) Platinum-resistant ovarian cancer: From mechanisms to treatment strategies[J\/OL]. Genes Dis 13(2):101801. https:\/\/doi.org\/10.1016\/j.gendis.2025.101801","journal-title":"Genes Dis"},{"key":"12584_CR5","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/j.bcp.2022.115323","volume":"206","author":"ROMANI A M P","year":"2022","unstructured":"Romani AMP (2022) Cisplatin in cancer treatment[J\/OL]. Biochem Pharmacol 206:115323. https:\/\/doi.org\/10.1016\/j.bcp.2022.115323","journal-title":"Biochem Pharmacol"},{"key":"12584_CR6","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"GHOSHS Cisplatin","year":"2019","unstructured":"Cisplatin G (2019) The first metal based anticancer drug[J\/OL]. Bioorg Chem 88:102925. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102925","journal-title":"Bioorg Chem"},{"issue":"5","key":"12584_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X CHEN","year":"2021","unstructured":"Chen X, Kang R, Kroemer G et al (2021) Broadening horizons: the role of ferroptosis in cancer[J\/OL]. Nat Rev Clin Oncol 18(5):280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"12584_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J PRAT","year":"2014","unstructured":"Prat J (2014) Prat J; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum.. Int J Gynaecol Obstet 124(1):1\u20135. https:\/\/doi.org\/10.1016\/j.ijgo.2013.10.001","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"12584_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/15548627.2014.998931","volume":"11","author":"SF ZHANG","year":"2015","unstructured":"Zhang SF, Wang XY, Fu ZQ et al (2015) TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer[J\/OL]. Autophagy 11(2):225\u2013238. https:\/\/doi.org\/10.1080\/15548627.2014.998931","journal-title":"Autophagy"},{"key":"12584_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-023-01516-8","author":"X SHEN","year":"2023","unstructured":"Shen X, Wang G, He H et al (2023) SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer[J\/OL]. Breast cancer (Tokyo Japan). https:\/\/doi.org\/10.1007\/s12282-023-01516-8","journal-title":"Breast cancer (Tokyo Japan)"},{"issue":"14","key":"12584_CR11","doi-asserted-by":"publisher","first-page":"15650","DOI":"10.1002\/cam4.6167","volume":"12","author":"H ABE","year":"2023","unstructured":"Abe H, Kamimura K, Okuda S et al (2023) BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis[J\/OL]. Cancer Med 12(14):15650\u201315663. https:\/\/doi.org\/10.1002\/cam4.6167","journal-title":"Cancer Med"},{"key":"12584_CR12","doi-asserted-by":"publisher","first-page":"100629","DOI":"10.1016\/j.ctarc.2022.100629","volume":"33","author":"S SAMBASIVAN","year":"2022","unstructured":"Sambasivan S (2022) Epithelial ovarian cancer: Review article[J\/OL]. Cancer Treat Res Commun 33:100629. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100629","journal-title":"Cancer Treat Res Commun"},{"issue":"3","key":"12584_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/cancers15030865","volume":"15","author":"H ZHENG","year":"2023","unstructured":"Zheng H, Stenius U, H\u00f6gberg J (2023) Translocation of Endonuclease G in Respiratory Epithelial Cells: A New Mode Action for DNA Damage Induced by Crystalline Silica Particles[J\/OL]. Cancers 15(3):865. https:\/\/doi.org\/10.3390\/cancers15030865","journal-title":"Cancers"},{"issue":"23","key":"12584_CR14","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.4155\/fmc-2022-0252","volume":"14","author":"C DONG","year":"2022","unstructured":"Dong C, Wang Y, Tu Z et al (2022) Recent advances in ATM inhibitors as potential therapeutic agents[J\/OL]. Future Med Chem 14(23):1811\u20131830. https:\/\/doi.org\/10.4155\/fmc-2022-0252","journal-title":"Future Med Chem"},{"issue":"8","key":"12584_CR15","doi-asserted-by":"publisher","first-page":"103662","DOI":"10.1016\/j.drudis.2023.103662","volume":"28","author":"B PRIYA","year":"2023","unstructured":"Priya B, Ravi S (2023) Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic[J\/OL]. Drug Discovery Today 28(8):103662. https:\/\/doi.org\/10.1016\/j.drudis.2023.103662","journal-title":"Drug Discovery Today"},{"key":"12584_CR16","doi-asserted-by":"crossref","unstructured":"Guffanti F, Fruscio R, Rulli E, Damia G (2016) The impact of DNA damage response gene polymorphisms on therapeutic outcomes in late stage ovarian cancer. Sci Rep 6:38142. https:\/\/pubmed.ncbi.nlm.nih.gov\/27905519\/.","DOI":"10.1038\/srep38142"},{"issue":"18","key":"12584_CR17","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1016\/j.cell.2025.05.046","volume":"188","author":"Y LEE K S, MIN J G, CHEONG","year":"2025","unstructured":"Lee KS, Min JG, Cheong Y et al (2025) Functional assessment of all ATM SNVs using prime editing and deep learning[J\/OL]. Cell 188(18):5081\u20135099e27. https:\/\/doi.org\/10.1016\/j.cell.2025.05.046","journal-title":"Cell"},{"issue":"27","key":"12584_CR18","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/onc.2011.21","volume":"30","author":"D PALMIERI","year":"2011","unstructured":"Palmieri D, Valentino T, D\u2019angelo D et al (2011) HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents[J\/OL]. Oncogene 30(27):3024\u20133035. https:\/\/doi.org\/10.1038\/onc.2011.21","journal-title":"Oncogene"},{"key":"12584_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jcis.2023.07.183","volume":"651","author":"K ZHANG","year":"2023","unstructured":"Zhang K, Wang J (2023) UCNPs-based nanoreactors with ultraviolet radiation-induced effect for enhanced ferroptosis therapy of tumor[J\/OL]. J Colloid Interface Sci 651:567\u2013578. https:\/\/doi.org\/10.1016\/j.jcis.2023.07.183","journal-title":"J Colloid Interface Sci"},{"key":"12584_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08856-w","author":"Q FENG","year":"2023","unstructured":"Feng Q, Hao S, Fang P et al (2023) Role of GPX4 inhibition-mediated ferroptosis in the chemoresistance of ovarian cancer to Taxol in vitro[J\/OL]. Mol Biol Rep. https:\/\/doi.org\/10.1007\/s11033-023-08856-w","journal-title":"Mol Biol Rep"},{"issue":"1","key":"12584_CR21","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1038\/s41598-024-57196-7","volume":"14","author":"J ZHU","year":"2024","unstructured":"Zhu J, Zhu H, Zhu Q et al (2024) The roles of autophagy, ferroptosis and pyroptosis in the anti-ovarian cancer mechanism of harmine and their crosstalk[J\/OL]. Sci Rep 14(1):6504. https:\/\/doi.org\/10.1038\/s41598-024-57196-7","journal-title":"Sci Rep"},{"issue":"29","key":"12584_CR22","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2017.11","volume":"36","author":"D BASULI","year":"2017","unstructured":"Basuli D, Tesfay L, Deng Z et al (2017) Iron addiction: a novel therapeutic target in ovarian cancer[J\/OL]. Oncogene 36(29):4089\u20134099. https:\/\/doi.org\/10.1038\/onc.2017.11","journal-title":"Oncogene"},{"issue":"1\u20132","key":"12584_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"S YANG W","year":"2014","unstructured":"Yang W S, Sriramaratnam R, Welsch M E et al (2014) Regulation of ferroptotic cancer cell death by GPX4[J\/OL]. Cell 156(1\u20132):317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"issue":"Suppl 2","key":"12584_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/1471-0528.17327","volume":"129","author":"X WU","year":"2022","unstructured":"Wu X, Qin Shen S (2022) High co-expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer[J\/OL]. BJOG: Int J Obstet Gynecol 129(Suppl 2):40\u201349. https:\/\/doi.org\/10.1111\/1471-0528.17327","journal-title":"BJOG: Int J Obstet Gynecol"},{"issue":"9","key":"12584_CR25","doi-asserted-by":"publisher","first-page":"16036","DOI":"10.18632\/oncotarget.13917","volume":"8","author":"S SUN","year":"2016","unstructured":"Sun S, Cai J, Yang Q et al (2016) The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets[J\/OL]. Oncotarget 8(9):16036\u201316051. https:\/\/doi.org\/10.18632\/oncotarget.13917","journal-title":"Oncotarget"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12584-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:43:30Z","timestamp":1786628610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12584-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12584"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12584-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this study does not involve any intervention on the patients and all methods in this study were conducted in compliance with relevant regulations and ethical principles such as the Declaration of Helsinki. This study was approved by the Ethics Committee of the Jiangxi Maternal and Child Health Care Hospital (January 2024, EC-KY-2024013) and obtained informed consent from all participants.","order":1,"name":"Ethics","label":"Compliance with ethical standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. There are no conflicts of interest associated with in this article. All the authors declare that they have no competing interests. Neither the entire study nor any part of it has been published or accepted for publication or is under consideration for publication elsewhere.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1399"}}